0
Upcoming Allied Market Research
2023
Pilocarpine Market

Pilocarpine Market

by Type (Injection, Eye Drop), by Application (Eye Clinic, Hospital, Others) : Global Opportunity Analysis and Industry Forecast, 2022-2032

Report Code: A50555
Pages: NA
May 2023 | 41 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 
Pilocarpine is a medication that belongs to a class of drugs called cholinergic agonists. It works by stimulating certain nerves and increasing the secretion of saliva and sweat, and also causes constriction of the pupils (miosis) and relaxation of the ciliary muscle in the eye, which can improve vision in people with certain eye conditions. Pilocarpine is primarily used to treat conditions such as dry mouth (xerostomia) caused by radiation therapy or certain medications, and glaucoma, a condition characterized by increased pressure within the eye that can damage the optic nerve and lead to vision loss.
In addition, pilocarpine may also be used to treat other conditions, such as Sjogren's syndrome (an autoimmune disorder that affects the moisture-producing glands of the body), cystic fibrosis (a genetic disorder that affects the lungs and digestive system), and certain neurological conditions that affect the autonomic nervous system. This is available in various forms, including eye drops, tablets, and oral solution. It should only be used under the supervision of a healthcare provider, as it can have potential side effects, such as sweating, flushing, headache, dizziness, and changes in vision. 
The pilocarpine market is primarily driven by its therapeutic applications in the treatment of dry mouth and glaucoma. Dry mouth is a common side effect of many medications, as well as a symptom of radiation therapy, and pilocarpine can be effective in increasing the production of saliva in these patients. Pilocarpine is also used in the treatment of glaucoma, a condition that affects millions of people globally and can lead to blindness if left untreated. As such, the increasing prevalence of these conditions is driving demand for pilocarpine and contributing to market growth. In addition to these primary drivers, technological advancements in drug delivery systems are also expected to contribute to the growth of this market. For example, the development of sustained-release formulations and innovative drug delivery systems that enhance the bioavailability and efficacy of pilocarpine may increase its uptake and use.
Furthermore, the increasing availability of pilocarpine in emerging economies is also expected to drive market growth, as more patients in these regions gain access to this medication. However, it is important to note that the market growth may be limited by the potential side effects of pilocarpine and the availability of alternative treatment options. Also, technological advancements in drug delivery systems are expected to drive growth in thismarket. The development of new and innovative drug delivery systems, such as sustained-release formulations, transdermal patches, and ophthalmic inserts, can improve the bioavailability and efficacy of pilocarpine, which can lead to better patient outcomes and increased demand for the medication.
Sustained-release formulations, for example, are designed to release the medication slowly over an extended period of time, which can reduce the frequency of dosing and increase patient compliance. This can be particularly beneficial for patients with dry mouth, who may require multiple daily doses of pilocarpine to manage their symptoms. In addition, ophthalmic inserts, which can be placed directly into the eye, can also improve the delivery of pilocarpine in the treatment of glaucoma. These inserts can provide a sustained release of the medication and can help to maintain consistent drug levels in the eye, which is important for managing intraocular pressure.
 
New product launches to flourish in the market
In January 2021, Upsher-Smith Laboratories announced the launch of its Pilocarpine Hydrochloride tablets in the U.S. The tablets are available in strengths of 5 mg and 7.5 mg and are indicated for the treatment of dry mouth symptoms caused by Sjogren's syndrome. Also, in February 2021, Lupin Limited launched its Pilocarpine Hydrochloride tablets in the U.S. The tablets are available in strengths of 5 mg and 7.5 mg and are indicated for the treatment of dry mouth symptoms caused by Sjogren's syndrome. Moreover, in September 2020, Bausch Health Companies Inc. launched its new Vyzulta eye drops in the U.S. Vyzulta is a once-daily eye drop that combines latanoprost and pilocarpine to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
These product launches demonstrate the continued interest and investment in the pilocarpine market, as companies work to bring new and innovative treatments to market to address the unmet needs of patients.
Segment Overview: 
By type: The pilocarpine market is divided into injection and eye drop. Injections are typically used to treat glaucoma and reduce intraocular pressure, while eye drops are used to treat dry eye and increase tear production. Injections tend to be more expensive than eye drops, as they require more highly trained practitioners to administer. Both types of pilocarpine can be used to treat a range of conditions, though it's important to speak with a doctor or ophthalmologist before beginning treatment.
 
By application: The pilocarpine market is divided into eye clinic, hospital, and others. Eye clinics are specialized healthcare facilities that focus on the diagnosis and treatment of eye-related conditions. Pilocarpine is commonly used by ophthalmologists and optometrists in eye clinics to treat conditions such as glaucoma, which is a leading cause of blindness. Also, hospitals are another important market for pilocarpine, particularly for patients who have advanced cases of glaucoma or other eye conditions. In hospitals, pilocarpine may be used by ophthalmologists, general practitioners, or other medical professionals to treat a wide range of eye-related conditions. The "others" category may include a range of healthcare providers, such as primary care clinics, urgent care centers, and long-term care facilities. While these providers may not specialize in the treatment of eye conditions, they may still use pilocarpine to treat certain patients who have been diagnosed with glaucoma or other eye-related conditions.
 
By region: The Asia-Pacific pilocarpine market is growing with a high CAGR owing to a large and aging population in the region, which is at a higher risk for developing eye diseases such as glaucoma. As the population continues to grow, so does the demand for effective treatments such as pilocarpine. With improving access to healthcare and increasing awareness of eye health, more patients in the Asia-Pacific region are seeking treatment for eye conditions. This is driving demand for medications such as pilocarpine. Moreover, advancements in technology have led to the development of new formulations of pilocarpine, which are more effective and easier to use than traditional formulations. This has increased the appeal of pilocarpine for both patients and healthcare providers. Also, many governments in the Asia-Pacific region are investing in healthcare infrastructure and initiatives to improve access to quality care for their citizens. This is creating new opportunities for pharmaceutical companies to expand their presence in the region and offer innovative treatments such as pilocarpine.
 
Competitive analysis and profiles of the major players in the pilocarpine market, such as Akorn Inc., Aurobindo Pharma Ltd., Impax Business Solutions Ltd., Kissei, Novartis AG, LGM Pharma, Rebel Distributors, SANDOZ AGRICARE LTD., Santen Pharmaceutical, and SOMERSET THERAPS. Major players have adopted product launch and acquisition as key developmental strategies to improve the product portfolio of the pilocarpine market.   

Pilocarpine Market Report Highlights

Aspects Details
By Type
  • Injection
  • Eye Drop
By Application
  • Eye Clinic
  • Hospital
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players Kissei, Novartis AG, Akorn Inc., SOMERSET THERAPS, impax business solutions limited, Santen Pharmaceutical, SANDOZ AGRICARE LIMITED, Rebel Distributors, Aurobindo Pharma Ltd, lgm pharma
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Pilocarpine Market

Start reading.
This Report and over 19,981+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers